Tag: Healthcare Policy
Suspend U.S. patents on medicines to fight U.S. tariffs
In the wake of the recent imposition of 25% tariffs on goods from Canada by the Trump administration, the Canadian government is responding with tariffs of its own. Amidst this escalating trade conflict, there...
Reforming FDA to Help Rare Disease Patients
President Donald Trump has the potential to revolutionize the landscape of rare disease treatments and save countless American lives through strategic policy changes, innovative science, and strong leadership within government agencies. This ambitious claim...
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks Controversy President Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has stirred a heated debate among policymakers and healthcare experts. The...
Debate over GLP-1 Drugs in Trump Administration: What You Need to Know
Debate Over GLP-1 Drugs in Trump Administration: What You Need to Know In a whirlwind of developments in the biotech world, major restructuring at Editas Medicine, a new commercialization strategy from Ionis Pharmaceuticals, and differing...
Access to Affordable Birth Control in Certain States is Declining
A renewed focus on ensuring access to affordable birth control is not helping women in states with strict abortion laws. In places like Tuscaloosa, Alabama, clinics like WAWC Healthcare are struggling to provide low-cost...
